Results 221 to 230 of about 27,451 (261)
Some of the next articles are maybe not open access.

Related searches:

Sclerotherapy

DeckerMed Vascular and Endovascular Surgery, 2020
Sclerotherapy involves the injection of a caustic solution into an abnormal vein so as to cause localized destruction of the venous intima and obliteration of the vessel. Over the past 50 years, improvements in the technology have greatly enhanced the results achievable with sclerotherapy.
Khalil H. Chamseddin, Melissa L Kirkwood
openaire   +1 more source

Complications of Sclerotherapy

Seminars in Cutaneous Medicine and Surgery, 2007
Sclerotherapy is the systematic, targeted elimination of intracutaneous and subcutaneous varicose, reticular, telangiectasias by the injection of a locally irritating chemical substance, called a sclerosant. The endpoint of this process is functionally analogous to surgical removal of a vein. However, regardless of the best of intentions, complications
Robert A. Weiss, Girish S. Munavalli
openaire   +3 more sources

Advances in Sclerotherapy

Dermatologic Clinics, 1995
Although venous systems are inherently variable, the treatment of varicose and telangiectatic leg veins can be approached in a logical, systematic fashion (Table 4). Instead of randomly injecting as many veins as possible in a given period of time, venous regions or entire abnormal superficial venous networks related to incompetent perforators should ...
Mitchel P. Goldman, Robert A. Weiss
openaire   +3 more sources

Consensus for Sclerotherapy

Dermatologic Surgery, 2014
The American Society for Dermatologic Surgery (ASDS) periodically develops consensus documents for its members concerning various aspects of dermatologic surgery. Unwanted and painful leg veins are a very widespread problem. Many advances in sclerotherapy of varicose and telangiectatic leg veins have occurred since the previous consensus documents.In ...
Jeffrey T.S. Hsu   +4 more
openaire   +3 more sources

Microfoam Sclerotherapy

Seminars in Cutaneous Medicine and Surgery, 2005
Sclerosant microfoam is composed of microbubbles of room or air carbon dioxide (CO(2)). When air is mixed into the surfactant liquid sclerosant, microbubbles of reduced diameter can be obtained of sufficient stability to be injected into the vessels. The area of liquid on the surface is enormously increased in inverse proportion to the diameter of the ...
Pedro, Redondo, Juan, Cabrera
openaire   +2 more sources

Cosmetic sclerotherapy

Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2017
Telangiectasias and spider veins are considered a common cosmetic concern for both women and men. Sclerotherapy is a frequently used, low-risk, and highly successful method to treat these venous problems. This article reviews the pathophysiology and diagnosis of telangiectasias and reticular veins as well as the currently available agents and ...
Jennifer J, Watson, M Ashraf, Mansour
openaire   +2 more sources

Sclerotherapy and foam sclerotherapy for varicose veins

Phlebology: The Journal of Venous Disease, 2009
Objectives To review published evidence concerning treatment of varicose veins using ultrasound-guided foam sclerotherapy (UGFS) to assess the safety and efficacy of this treatment. Methods Medical literature databases including MedLine, Embase and DH-DATA were searched for recent literature concerning UGFS.
openaire   +3 more sources

Home - About - Disclaimer - Privacy